Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series - Wikidata - awgldk - TriplyDB

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series

http://www.wikidata.org/entity/Q34669352

about

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case report Prognostic implications of PIK3CA amplification in curatively resected liposarcoma VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma.Contemporary Management of Retroperitoneal Soft Tissue Sarcomas.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas.Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study().Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.Effective apatinib treatment of pleomorphic liposarcoma: A case report.High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study.Synchronous coexistence of liver metastases from cecal leiomyosarcoma and rectal adenocarcinoma: A case report.Pazopanib monotherapy in the treatment of pretreated, metastatic uterine sarcoma: a single-center retrospective study.Current status of proteomics of soft tissue sarcomas.Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone.Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study.

P2860

Q36546559-C8A6EC0D-1A84-4107-B45D-F0892B9D00D9 Q36546673-75E82197-277F-43F8-B7DB-27FEA34D8E40 Q37004340-18AC41C8-778E-4191-BFB5-F6E21809573F Q37015759-44075186-F6B8-4165-AC43-419FD442C1BF Q37164989-1F843E44-6F70-4C62-8C09-41AB57919602 Q37269360-A4F1FF4C-89C3-4EB0-80C4-48D321F7094C Q37619546-88F6720C-C68B-4A28-B478-E0EE5B59AE1E Q38532600-49F374B6-5890-458F-9FD3-8CC9F5A57088 Q38591828-13C28AD7-C3CE-4BE6-A91D-45D6FF9B05F4 Q39191957-05D6F81B-296E-4495-8523-173F3139E744 Q39415429-09AC6533-B70C-46A4-9C93-847F22B294A5 Q39444949-F552F0EB-17D3-4333-B6CA-B3D4F3935156 Q41105379-45D9F350-1125-408A-B6EE-B343BFEDCB28 Q41521470-108DA0FC-A9DC-4F8D-ADB1-8DE20B2672D5 Q41950745-C6593C86-E764-4B09-8C58-450C8CCA8B24 Q42025297-82E705D5-D533-494D-8F3E-A3C4770BE8DE Q47139812-4C586576-6B91-492A-A4B8-B948C20B1975 Q47640603-CE4949F9-AF21-429C-B807-4D87A39B5A8F Q47692353-3C39A46C-190C-4B3A-9CB9-1080990C7824 Q48005435-6879C1A5-B4F8-460D-B056-99FAD80C60B7 Q48563213-A906090E-AB68-4FCD-8997-7A20E66BE4D2

P2860

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series

http://www.wikidata.org/entity/Q34669352

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Efficacy of pazopanib monother ...... a: a retrospective case series

@ast

Efficacy of pazopanib monother ...... a: a retrospective case series

@en

Efficacy of pazopanib monother ...... a: a retrospective case series

@nl

type

label

Efficacy of pazopanib monother ...... a: a retrospective case series

@ast

Efficacy of pazopanib monother ...... a: a retrospective case series

@en

Efficacy of pazopanib monother ...... a: a retrospective case series

@nl

prefLabel

Efficacy of pazopanib monother ...... a: a retrospective case series

@ast

Efficacy of pazopanib monother ...... a: a retrospective case series

@en

Efficacy of pazopanib monother ...... a: a retrospective case series

@nl

P1433

Q34669352-2A777999-91F3-40D9-BBC0-C2132C579A74

P1476

Q34669352-82C5D829-6867-477D-A0B7-6B45847AD58E

P2093

Q34669352-06EDDD57-39E4-4F3D-8C65-98558FA30732

Q34669352-1255E5B4-2ED2-4B15-8462-7161A8513347

Q34669352-12735148-0551-4165-9F23-421CE30FCFF4

Q34669352-1EABD352-CED8-4DEE-9594-AA7A3CDAE9AB

Q34669352-2F1C58E3-CFFE-4003-AE02-848313AC25EC

Q34669352-5B4B002E-702E-40B3-AE32-950D710E6BDC

Q34669352-8E02BB64-ADA4-474B-A68C-F64B451A30C7

Q34669352-AF262A7B-8BDE-4BA8-A12B-2D2DC83B7A44

Q34669352-B6A23204-2251-4E0F-AEFC-DFE3DF37E91F

Q34669352-FB169965-6CAB-4D6E-A2F1-4C3E65391D15

P2860

Q34669352-3B0BE7EE-C8A3-4DBC-AE26-F9436A03892A

Q34669352-43F2689B-C2B4-40BC-854F-3713E0C2E297

Q34669352-47CE9F1F-AE98-4B28-BB41-5150DD2829E7

Q34669352-4C7F553D-1F7B-447F-A862-9BD76200D7BC

Q34669352-4F68793F-7A3C-43AE-940C-BB1BD4C4662A

Q34669352-5600AC34-4E34-4357-9A61-6EC2A752BC28

Q34669352-64DD019D-8A90-405F-90B4-662AEBC3231A

Q34669352-74FA4D45-05A9-4DC7-9542-23B8DD416BDF

Q34669352-866A6BFD-D218-484F-8B6E-D3374989BD21

Q34669352-964E0A59-434F-4380-B7E5-F6561B8D3321

P2888

Q34669352-5716185B-073B-471D-B3F1-12603F07F695

P304

Q34669352-F72D7B4D-1B5B-402C-A92F-CD94054CF08E

P31

Q34669352-F3703AD2-3990-45B8-937A-1F8E49ED45CD

P356

Q34669352-5034F49E-DDBB-471B-BE5F-65B52786DFF6

P407

Q34669352-8E73BB27-59B4-4561-B066-286E560CC17B

P478

Q34669352-D09F1C99-33F0-4BC9-93B3-19FA76A920A3

P50

Q34669352-99BF88D9-E250-4274-892B-4C4BDA219A36

P577

Q34669352-17EB5BBB-4434-44F9-A18D-275609D98643

P5875

Q34669352-7447B065-0DEC-4C22-9795-398F5E1A109E

P6179

Q34669352-9674DAF0-23D6-442D-9912-FE7B98ED44B8

P698

Q34669352-C626DDA4-E9D5-442A-A78F-8AF72C8EB718

P932

Q34669352-C1C888A1-B416-4E7B-8E1E-E8E7D6F94FCD

P356

S12885-015-1160-X

P1433

P1476

Efficacy of pazopanib monother ...... a: a retrospective case series

@en

P2093

Hyo Song Kim

http://www.w3.org/2001/XMLSchema#string

Jeeyun Lee

http://www.w3.org/2001/XMLSchema#string

Kwai Han Yoo

http://www.w3.org/2001/XMLSchema#string

Kyoo-Ho Shin

http://www.w3.org/2001/XMLSchema#string

Se Hoon Park

http://www.w3.org/2001/XMLSchema#string

Soo Hee Kim

http://www.w3.org/2001/XMLSchema#string

Su Jin Lee

http://www.w3.org/2001/XMLSchema#string

Sung Joo Kim

http://www.w3.org/2001/XMLSchema#string

Yong Jin Cho

http://www.w3.org/2001/XMLSchema#string

Yoon La Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Pazopanib in the treatment of soft tissue sarcoma

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy.

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

P2888

s12885-015-1160-x

P304

154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-015-1160-X

http://www.w3.org/2001/XMLSchema#string

P407

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275048903

http://www.w3.org/2001/XMLSchema#string

P6179

1037217746

http://www.w3.org/2001/XMLSchema#string

P698

25885855

http://www.w3.org/2001/XMLSchema#string

P932

4438639

http://www.w3.org/2001/XMLSchema#string